J&J, Legend cell therapy approved by FDA for multiple myeloma
Bio Pharma Dive
FEBRUARY 28, 2022
The CAR-T treatment is the second to be approved in the U.S. for the blood cancer, following Bristol Myers Squibb and 2Seventy bio's Abecma
February, 2022
285 
Lung cancer deaths decline but.
World of DTC Marketing
FEBRUARY 17, 2022
The mortality rate from lung cancer has dropped in recent decades—by 56% in men from 1990 to 2019 and by 32% in women from 2002 to 2019. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Simons Foundation gives $4 million to CUNY Graduate Center to diversify astrophysics education
Scienmag
FEBRUARY 9, 2022
NEW YORK, February 9, 2022– Astrophysics is one of the most popular science fields, igniting the imaginations of many as they learn about it from television shows or news of space exploration. Like many other STEM fields, though, it lags in attracting students of color.
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Data from first DMT-assisted clinical trial revealed
Pharma Times
FEBRUARY 24, 2022
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Looking for a Summer Internship? You’d Better Act Fast
Intouch Solutions
FEBRUARY 25, 2022
Internships are an ideal way to get real work experience and figure out if you’re a good fit for a particular industry, but how do you score one when much of the professional world is still working remotely?
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Biogen continues to sink
World of DTC Marketing
FEBRUARY 7, 2022
Board members and senior executives are bailing out of Biogen but will there be enough life vests? What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down.
Ways to Access Affordable Mental Health Services
Pharma Mirror
FEBRUARY 24, 2022
Taking care of your mental health can be affordable. All you will have to do is choose therapy options that fit in your budget. In this article, we have outlined the most affordable therapy options.
NJIT reaffirmed as an elite research university, retains R1 classification
Scienmag
FEBRUARY 3, 2022
New Jersey Institute of Technology (NJIT) has reaffirmed its status among the nation’s most elite and productive research institutions by once again achieving an R1 status — the highest designation — by the Carnegie Classification.
Pharma Franchise Business Is Beneficial For the Indian Pharmaceutical Market
Fossil Remedies
FEBRUARY 18, 2022
PCD Pharma Franchise Business. Why are more aspirants willing to make a career in the field of pharmaceuticals? It is because the business is not only promising, but it is going to remain profitable for many years. People have become health conscious and they want to maintain fitness.
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Intouch Creatives on Super Bowl LVI Ads: Toyota Nailed It; T-Mobile Dropped the Ball
Intouch Solutions
FEBRUARY 15, 2022
Each year, we ask Intouch creatives to share their thoughts on the latest Super Bowl ads. This year, for Super Bowl LVI, we’re back with more creatives and more reactions. But wait: When you get a bunch of creatives (and one strategic planner) “in a room together,” can you get quick consensus?
Intellia presses forward with new results for pioneering CRISPR drug
Bio Pharma Dive
FEBRUARY 28, 2022
The findings build on early evidence that gene editing inside the body could safely and effectively treat disease, and suggest the effects of Intellia's medicine might last
When it comes to telehealth it’s not numbers
World of DTC Marketing
FEBRUARY 18, 2022
Business Insider formed a relationship with eMarketer for so-called “intelligence.” ” Their report on telehealth has numbers, but that’s not what’s important.
MBMV invests in international bio-tech startup Arcensus GmbH
Pharma Mirror
FEBRUARY 24, 2022
Hoboken, NJ, Rostock/Berlin, Germany, Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment.
Mandatory COVID Vaccination Policy Template
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Your microbiome shapes your life. But where did it come from?
Scienmag
FEBRUARY 9, 2022
Baltimore, MD— The gut microbiome is an ecosystem of hundreds to thousands of microbial species living within the human body. These populations affect our health, fertility, and even our longevity. But how do they get there in the first place?
Data day: Trial results deliver hope for prostate cancer patients
Pharma Times
FEBRUARY 18, 2022
New combination treatment can significantly reduce the risk of death among prostate cancer patients
Lürzer’s Archive Recognizes Intouch Group as a 2021 Top Five Creative Agency
Intouch Solutions
FEBRUARY 3, 2022
Accolades Confirm Intouch as Among the Fastest-Rising Creative Agencies in the World. New York, NY — (Feb.
BioMarin says gene therapy hold will endure as FDA questions cancer risk
Bio Pharma Dive
FEBRUARY 18, 2022
According to BioMarin, the regulator has requested additional data to assess the "theoretical" cancer risk to the treatment, information that will take "several quarters" to collect
How agencies can help pharma DTC
World of DTC Marketing
FEBRUARY 3, 2022
The way people make treatment decisions is changing because of COVID. Agencies are responsible for working with clients to implement changes that support brand objectives. It won’t be easy and means changing the mindset from a vendor to a strategic partner.
MBMV invests in international bio-tech startup Arcensus GmbH
Pharma Mirror
FEBRUARY 24, 2022
Hoboken, NJ, Rostock/Berlin, Germany, Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment.
Even the smallest pollution particles change the rainfall regime in the Amazon
Scienmag
FEBRUARY 4, 2022
Even the finest particles of pollution influence the process of cloud formation and the rainfall regime.
Condition Critical: Court Interprets Orphan Drug Exclusivity Broadly
FDA Law Blog
FEBRUARY 16, 2022
By Sara W. Koblitz — Because a drug is designated an “Orphan” if it is intended to treat a “rare condition,” the condition itself always has been integral to Orphan Drug Exclusivity.
6 Digital Health Takeaways From CES 2022 That Will Change Healthcare as We Know It
Intouch Solutions
FEBRUARY 1, 2022
Digital health investments skyrocketed in 2021, increasing 79% from 2020, according to a year-end report by CB Insights , a marketing intelligence firm.
FDA sends signal with tough questions of Lilly at cancer drug meeting
Bio Pharma Dive
FEBRUARY 10, 2022
The agency criticized Eli Lilly for using a trial run in China to seek approval of an immunotherapy it licensed from Innovent Biologics. Outside advisers agreed in a decisive vote that could have repercussions for several other drugmakers
Mental health apps can be useless
World of DTC Marketing
FEBRUARY 8, 2022
According to the Lancet, a medical journal, the incidence of depression and anxiety has soared in the pandemic—by more than 25% globally in 2020. That, combined with more people using online services, has led to a boom in mental-health apps. But are they safe and effective?
V-01 as a Sequential Booster Can Produce Good Protection against Omicron Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma
Pharma Mirror
FEBRUARY 19, 2022
HONG KONG, Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19. Following the Delta and Beta variants, Omicron variant emerged at the end of 2021, and its enhanced infectivity has cast a shadow over the global COVID-19 control.
New simple method for surveying amphibians: A vital contribution to conservation efforts
Scienmag
FEBRUARY 20, 2022
An international collaborative research group consisting of members from 7 institutions has developed a method of determining which amphibious species (types of frog, newt and salamander) inhabit an area.
Top 3 Things to Know About Engaging Oncologists in 2022
Pharma Marketing Network
FEBRUARY 10, 2022
Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education.
Scientists discover immune cell surveillance mechanism
Pharma Times
FEBRUARY 15, 2022
Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA
Sarepta reveals gene editing alliance with biotech exploring alternative delivery methods
Bio Pharma Dive
FEBRUARY 1, 2022
The collaboration with GenEdit, a South San Francisco startup developing new ways of delivering gene editing tools into the body, dates back to December 2020, but has recently begun to advance
Is it too late for Biogen?
World of DTC Marketing
FEBRUARY 2, 2022
Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment.
QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM
Pharma Mirror
FEBRUARY 19, 2022
NOTTINGHAM (UK) Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech industry – announces that it has integrated drug substance into its flagship Translational Pharmaceutics® platform.
Coordinated conservation and restoration critical to save Asia’s threatened native trees
Scienmag
FEBRUARY 1, 2022
A new study has revealed that the rich native tree diversity in South and Southeast Asia is at risk of potential extinction.
J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need
NY Times
FEBRUARY 8, 2022
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory. Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Factories and Manufacturing Johnson & Johnson
Let's personalize your content